Ocular Therapeutix
OCUL
#5577
Rank
NZ$2.60 B
Marketcap
NZ$11.86
Share price
-0.08%
Change (1 day)
-38.18%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -NZ$0.53 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are NZ$52.05 Million. In 2025 the company made an earning of -NZ$0.48 Billion a decrease over its 2024 earnings that were of -NZ$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.53 Billion9.74%
2025 -NZ$0.48 Billion37.43%
2024 -NZ$0.35 Billion139.68%
2023 -NZ$0.15 Billion13.65%
2022 -NZ$0.13 Billion984.05%
2021 -NZ$11.77 Million-95.79%
2020 -NZ$0.28 Billion80.19%
2019 -NZ$0.16 Billion44.01%
2018 -NZ$0.11 Billion-5.38%
2017 -NZ$0.12 Billion41.79%
2016 -NZ$80.29 Million12.47%
2015 -NZ$71.39 Million38.75%
2014 -NZ$51.45 Million115.12%
2013 -NZ$23.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-NZ$20.13 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-NZ$9.2 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-NZ$0.29 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.31 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA